載入...

Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal

BACKGROUND: Four nonvitamin K antagonist oral anticoagulants (NOACs) are approved for the prevention of stroke in patients with nonvalvular atrial fibrillation and for the treatment of venous thromboembolism. These include the direct thrombin inhibitor dabigatran and the direct factor Xa inhibitors...

全面介紹

Na minha lista:
書目詳細資料
發表在:Crit Care
Main Authors: Brown, Karen S., Zahir, Hamim, Grosso, Michael A., Lanz, Hans J., Mercuri, Michele F., Levy, Jerrold H.
格式: Artigo
語言:Inglês
出版: BioMed Central 2016
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5034528/
https://ncbi.nlm.nih.gov/pubmed/27659071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-016-1422-2
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!